APA Citatie

Scott, L. J. (2018). Osimertinib as first-line therapy in advanced NSCLC: A profile of its use. Drugs Ther Perspect.

Chicago Style citaat

Scott, Lesley J. "Osimertinib As First-line Therapy in Advanced NSCLC: A Profile of Its Use." Drugs Ther Perspect 2018.

MLA citatie

Scott, Lesley J. "Osimertinib As First-line Therapy in Advanced NSCLC: A Profile of Its Use." Drugs Ther Perspect 2018.

Let op: Deze citaties zijn niet altijd 100% accuraat.